Cargando…

1459. Association of Antibiotic Prophylaxis Duration and Length of Stay in Patients Undergoing Coronary Artery Bypass Graft Procedure

BACKGROUND: Antibiotic prophylaxis in surgery is a standard measure to reduce the risk of microbial contamination following an incision. For most surgeries, a single dose of antibiotics is generally required. However, in patients undergoing coronary artery bypass graft (CABG) procedure, antibiotics...

Descripción completa

Detalles Bibliográficos
Autores principales: Alnaimi, Shaikha, Obaidi, Warda, Habra, Masa, Shoman, Bassam, Carr, Cornelia, Alhail, Moza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677775/
http://dx.doi.org/10.1093/ofid/ofad500.1296
_version_ 1785150209525809152
author Alnaimi, Shaikha
Obaidi, Warda
Habra, Masa
Shoman, Bassam
Carr, Cornelia
Alhail, Moza
author_facet Alnaimi, Shaikha
Obaidi, Warda
Habra, Masa
Shoman, Bassam
Carr, Cornelia
Alhail, Moza
author_sort Alnaimi, Shaikha
collection PubMed
description BACKGROUND: Antibiotic prophylaxis in surgery is a standard measure to reduce the risk of microbial contamination following an incision. For most surgeries, a single dose of antibiotics is generally required. However, in patients undergoing coronary artery bypass graft (CABG) procedure, antibiotics have been administered for ≥ 24 hours as data on the optimal duration is not sufficient. We aimed to correlate the duration of antibiotic prophylaxis in patients undergoing CABG with length of hospital stay (LOS). METHODS: We conducted a retrospective cohort study comparing LOS of patients undergoing CABG who received antibiotic prophylaxis for ≥ 24 hours (extended course group) and those who received it for < 24 hours (short course group). Inclusion criteria were adults who had undergone CABG between 01/09/2015 –01/03/2019 in a cardiology and cardiothoracic surgery hospital. Exclusion criteria were immunocompromised patients, in-hospital mortality and patients with a pre-existing infection. The primary outcome was LOS and we also explored other variables that may predict LOS. Effects were adjusted for confounders using a multivariate linear regression model. RESULTS: A total of 855 patients were identified. After exclusion, 840 were included in the analysis of which 425 (50.6%) received antibiotics for ≥ 24 hours and 415 (49.4%) received them for < 24 hours. The median LOS was 12.2 [IQR 11.0] days in the extended course group and 8.4 [IQR 8.8] days in the short course group, with a difference of 3.8 days (95% CI: 1.8-5.7), p-value < 0.001. However, after adjusting for potential confounders the difference was no longer significant, 1.7 days (95% CI: -0.23-3.7), p-value 0.083. Independent predictors of length of stay were, male gender, presence of chronic kidney disease, American Society of Anesthesiologists class, priority of the surgery and history of infection in the last 90 days. CONCLUSION: There is no statistically significant difference in LOS between short and extended antibiotic prophylaxis course in patients undergoing CABG procedure. Future work should explore the cost-effectiveness of short versus extended course antibiotic prophylaxis. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10677775
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106777752023-11-27 1459. Association of Antibiotic Prophylaxis Duration and Length of Stay in Patients Undergoing Coronary Artery Bypass Graft Procedure Alnaimi, Shaikha Obaidi, Warda Habra, Masa Shoman, Bassam Carr, Cornelia Alhail, Moza Open Forum Infect Dis Abstract BACKGROUND: Antibiotic prophylaxis in surgery is a standard measure to reduce the risk of microbial contamination following an incision. For most surgeries, a single dose of antibiotics is generally required. However, in patients undergoing coronary artery bypass graft (CABG) procedure, antibiotics have been administered for ≥ 24 hours as data on the optimal duration is not sufficient. We aimed to correlate the duration of antibiotic prophylaxis in patients undergoing CABG with length of hospital stay (LOS). METHODS: We conducted a retrospective cohort study comparing LOS of patients undergoing CABG who received antibiotic prophylaxis for ≥ 24 hours (extended course group) and those who received it for < 24 hours (short course group). Inclusion criteria were adults who had undergone CABG between 01/09/2015 –01/03/2019 in a cardiology and cardiothoracic surgery hospital. Exclusion criteria were immunocompromised patients, in-hospital mortality and patients with a pre-existing infection. The primary outcome was LOS and we also explored other variables that may predict LOS. Effects were adjusted for confounders using a multivariate linear regression model. RESULTS: A total of 855 patients were identified. After exclusion, 840 were included in the analysis of which 425 (50.6%) received antibiotics for ≥ 24 hours and 415 (49.4%) received them for < 24 hours. The median LOS was 12.2 [IQR 11.0] days in the extended course group and 8.4 [IQR 8.8] days in the short course group, with a difference of 3.8 days (95% CI: 1.8-5.7), p-value < 0.001. However, after adjusting for potential confounders the difference was no longer significant, 1.7 days (95% CI: -0.23-3.7), p-value 0.083. Independent predictors of length of stay were, male gender, presence of chronic kidney disease, American Society of Anesthesiologists class, priority of the surgery and history of infection in the last 90 days. CONCLUSION: There is no statistically significant difference in LOS between short and extended antibiotic prophylaxis course in patients undergoing CABG procedure. Future work should explore the cost-effectiveness of short versus extended course antibiotic prophylaxis. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677775/ http://dx.doi.org/10.1093/ofid/ofad500.1296 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Alnaimi, Shaikha
Obaidi, Warda
Habra, Masa
Shoman, Bassam
Carr, Cornelia
Alhail, Moza
1459. Association of Antibiotic Prophylaxis Duration and Length of Stay in Patients Undergoing Coronary Artery Bypass Graft Procedure
title 1459. Association of Antibiotic Prophylaxis Duration and Length of Stay in Patients Undergoing Coronary Artery Bypass Graft Procedure
title_full 1459. Association of Antibiotic Prophylaxis Duration and Length of Stay in Patients Undergoing Coronary Artery Bypass Graft Procedure
title_fullStr 1459. Association of Antibiotic Prophylaxis Duration and Length of Stay in Patients Undergoing Coronary Artery Bypass Graft Procedure
title_full_unstemmed 1459. Association of Antibiotic Prophylaxis Duration and Length of Stay in Patients Undergoing Coronary Artery Bypass Graft Procedure
title_short 1459. Association of Antibiotic Prophylaxis Duration and Length of Stay in Patients Undergoing Coronary Artery Bypass Graft Procedure
title_sort 1459. association of antibiotic prophylaxis duration and length of stay in patients undergoing coronary artery bypass graft procedure
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677775/
http://dx.doi.org/10.1093/ofid/ofad500.1296
work_keys_str_mv AT alnaimishaikha 1459associationofantibioticprophylaxisdurationandlengthofstayinpatientsundergoingcoronaryarterybypassgraftprocedure
AT obaidiwarda 1459associationofantibioticprophylaxisdurationandlengthofstayinpatientsundergoingcoronaryarterybypassgraftprocedure
AT habramasa 1459associationofantibioticprophylaxisdurationandlengthofstayinpatientsundergoingcoronaryarterybypassgraftprocedure
AT shomanbassam 1459associationofantibioticprophylaxisdurationandlengthofstayinpatientsundergoingcoronaryarterybypassgraftprocedure
AT carrcornelia 1459associationofantibioticprophylaxisdurationandlengthofstayinpatientsundergoingcoronaryarterybypassgraftprocedure
AT alhailmoza 1459associationofantibioticprophylaxisdurationandlengthofstayinpatientsundergoingcoronaryarterybypassgraftprocedure